and Stanley, 1984), studying angiotensin II interactions with its receptor (Petruzzelli et al .,
1985), crosslinking of vasoactive intestinal peptide to its receptor on human lymphoblasts
(Wood and O ’Dorisio, 1985), investigating insulin-dependent protein kinases (Petruzzelli et al .,
1985), identifying a cellular receptor for tumor necrosis factor (TNF) (Kull et al., 1985), affi n-
ity crosslinking of atrial natriuretic factor in aorta membranes (Vandelen et al., 1985), study-
ing the receptor for human interferon (Rashidbaigi et al., 1986), crosslinking of endorphin to
membranes rich in opioid receptors (Helmeste et al., 1986), immunoprecipitation studies of the
crosslinked complex of parathyroid hormone with its receptor (Wright et al., 1987), binding of
human interferon Y to its receptor (Novick et al., 1987), identifying the erythropoietin receptor
on Friend virus-infected erythroid cells (Sawyer et al., 1987), and binding of the p75 peptide to
an interleukin 2 receptor (Tsudo et al ., 1987).
Bis(sulfosuccinimidyl) subsrate (BS
3
) is an analog of DSS that contains sulfo-NHS esters
on both carboxylates. The affect of the negative charges provided by the sulfonate groups
lends water solubility to the compound. Prior organic solvent dissolution (before addition to
a reaction) is not necessary. The hydrophilicity of BS
3
also makes it membrane impermeable.
Therefore, cell labeling with BS
3
results in hydrophilic-region modifi cation and crosslinking,
targeting surface functionalities, whereas DSS is capable of targeting hydrophobic regions
within the membrane structure itself. As with DSS, BS
3
is non-cleavable, and thus all crosslinks
formed are irreversible. The reactivity of the sulfo-NHS esters is identical to NHS esters, being
highly reactive toward amines in the pH range of 7–9.
Reported applications of BS
3
include crosslinking of the -endorphin–calmodulin interac-
tion (Staros, 1982), crosslinking of the extracellular domain of intact human erythrocytes ’
anion exchange channel (Staros and Kakkad, 1983), crosslinking of hepatoma cytokeratin
fi laments (Ward et al., 1985), investigating the -lymphocyte Fc receptor for IgE (Lee and
Conrad, 1985; Staros et al., 1987), crosslinking of the tri-peptide Arg–gly–asp to an adhesion
receptor on platelets (Souza et al., 1988), crosslinking of the large and small subunits of cyto-
chrome b559 (Knoller et al., 1991), and for general receptor–ligand crosslinking (Waugh
et al., 1989). See also Dihazi and Sinz (2003), Koller et al. (2004), and Law et al. (2002)
for additional applications of BS
3
in proteomic applications. Also see Ishmael et al. (2005)
and Longshaw et al. (2004) for additional applications involving DSS in studying protein
interactions.
1.3. DST and Sulfo-DST
Disuccinimidyl tartarate (DST) is a homobifunctional NHS ester crosslinking reagent that
contains a central diol that is susceptible to cleavage with sodium periodate (Thermo Fisher).
DST forms amide linkages with -amines and -amines of proteins or other amine-containing
molecules ( Figure 4.7 ). The reagent is fairly insoluble in aqueous buffers, but it may be pre-
dissolved in THF, DMF, or DMSO prior to addition of an aliquot to a reaction. Optimal con-
ditions for reactivity include a pH range of 7–9 with no extraneous amines present that may
cross-react with the NHS esters. Avoid Tris, glycine, or imidazole buffers. Subsequent to conju-
gating proteins with DST, the crosslinks may be broken for analysis by treatment with 0.015 M
sodium periodate.
1. Homobifunctional NHS Esters 243